Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Votrient in Molecularly Selected Advanced NSCLC
NCT02193152Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in non-small cell lung cancer (NSCLC), sponsored by Washington University School of Medicine. Started Apr 2015; status: terminated.
02
Drugs
pazopanib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02193152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02193152.